Accession Therapeutics Limited
PrivateLast Round
Grant
Mar 24, 2026
Est. Valuation
$100.93M
Total Funding Raised
$44.23M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Accession Therapeutics Limited is a biopharmaceutical company developing a novel class of tumour-targeted immunotherapies through its proprietary TROCEPT platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accession Therapeutics Limited Comparables
Compare Accession Therapeutics Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KaliVir Immunotherapeutics | 87% | |
| TILT Biotherapeutics | 87% | |
| Theolytics | 86% | |
Accession Therapeutics Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 24, 2026 | ||||
| VC Round | Mar 18, 2026 | ||||
| VC Round | Dec 4, 2025 | ||||
| VC Round | Apr 25, 2024 | ||||
| Series A | Nov 21, 2022 | ||||
Seed | Sep 20, 2021 |
Key People
Founding team and executive leadership
Accession Therapeutics Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Birk Venture | Seed, Series A |
| Cancer Research UK | Series A |
| iGlobe Partners | VC Round, Series A |
| Primavera Venture Partners | Seed, VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Received $9M in grant funding from the European Commission.
- Mar 18, 2026
$7.6M round raised
Accession Therapeutics Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accession Therapeutics Limited's valuation, stock price, and market status.